TEZRULY
NDC 70954-592, Terazosin, solution, from ANI Pharmaceuticals, Inc..
- Product NDC
- 70954-592
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA218139
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70954-592 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERAZOSIN HYDROCHLORIDE1 mg/mL
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70954-592-10 | 70954059210 | 150 mL in 1 BOTTLE (70954-592-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/69582e0c-6569-490c-8c14-999f3750336f
Use it
Look up 70954-592 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70954-592 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70954-592. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.